By Ben Butkus

UniTaq Bio, an early-stage company founded by a former Life Technologies R&D director, recently debuted its flagship technology — a "universal" PCR/qPCR technology that it claims will allow users to detect tens or even hundreds of nucleic acid targets in a single reaction.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.